# What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Study · id `cardio:ct-nct04436978` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04436978](<https://clinicaltrials.gov/study/NCT04436978>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04436978

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT04436978. Randomized; single masking; primary purpose prevention. Start 2023-01-11 (actual); primary completion 2027-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT04436978, source copy `cardio:ctgov-nct04436978-2023-12-15`, retrieved 2026-10-26)
- Started: 2023-01-11 (actual) (ClinicalTrials.gov record NCT04436978, source copy `cardio:ctgov-nct04436978-2023-12-15`, retrieved 2026-10-26)
- Primary completion: 2027-10-01 (anticipated) (ClinicalTrials.gov record NCT04436978, source copy `cardio:ctgov-nct04436978-2023-12-15`, retrieved 2026-10-26)
- Completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT04436978, source copy `cardio:ctgov-nct04436978-2023-12-15`, retrieved 2026-10-26)
- Countries: Belgium; Netherlands (ClinicalTrials.gov record NCT04436978, source copy `cardio:ctgov-nct04436978-2023-12-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04436978-2023-12-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
- Acronym: WOEST-3
- Condition: Acute Coronary Syndrome
- Condition: Myocardial Infarction
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Condition: STEMI - ST Elevation Myocardial Infarction
- Condition: NSTEMI - Non-ST Segment Elevation MI
- Condition: Bleeding
- Condition: Stroke
- Condition: Stent Thrombosis
- Condition: Embolism
- Condition: Coronary Artery Disease
- Intervention (Drug): 30-day DAPT
- Intervention (Drug): Guideline-directed therapy
- Lead sponsor: St. Antonius Hospital
- Lead sponsor class: OTHER
- Collaborator: Daiichi Sankyo
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: St. Antonius Hospital (`cardio:org-st-antonius-hospital`)
- Registry lists this organization as a collaborator: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)

## Provenance

Content hash: 1a3ea5b26c686a46ce65a28e80e75820640345ce567a9342aa2f5992bbdf8e3e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
